Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2026-03-31
DOI
https://doi.org/10.1111/apt.70651
Citations
1
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
22.22
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination

Yash Hegde, Freddy Caldera
1 citations
Alimentary Pharmacology & Therapeutics
Hepatitis B Virus Studies
22.22
article

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination

Yash Hegde, Freddy Caldera
article en
1 citations

Abstract

No abstract available for this paper.
Alimentary Pharmacology & Therapeutics
University of Wisconsin–Madison (US), Wisconsin Division of Public Health (US)
Good health and well-being
Openalex Percentile: Top 1%
Hepatitis B Virus Studies
22.22
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination — Yash Hegde, Freddy Caldera · Alimentary Pharmacology & Therapeutics (2026) | TGRS Research Map | TGRS